Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
The Treasury Secretary, who emphasized that the situation was much different from the financial crisis almost 15 years ago, said the government would help depositors who are concerned about their money.
Kathryn Minshew, the CEO and founder of career development platform The Muse, said that there are some things a candidate can do to make sure their resume makes it through the system.
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
